8.5
CVE-2026-21997
- EPSS 0.02%
- Veröffentlicht 21.04.2026 20:34:58
- Zuletzt bearbeitet 01.05.2026 13:30:55
- Quelle secalert_us@oracle.com
- CVE-Watchlists
- Unerledigt
Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).
Daten sind bereitgestellt durch National Vulnerability Database (NVD)
Oracle ≫ Life Sciences Empirica Signal Version >= 9.2.1 <= 9.2.3
| Typ | Quelle | Score | Percentile |
|---|---|---|---|
| EPSS | FIRST.org | 0.02% | 0.064 |
| Quelle | Base Score | Exploit Score | Impact Score | Vector String |
|---|---|---|---|---|
| secalert_us@oracle.com | 8.5 | 3.1 | 4.7 |
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N
|
CWE-284 Improper Access Control
The product does not restrict or incorrectly restricts access to a resource from an unauthorized actor.